These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17990907

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J, Li P, Chiriboga L, Mizuguchi M, Yee H, Miller DC, Greco MA.
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [Abstract] [Full Text] [Related]

  • 3. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
    Kenerson HL, Aicher LD, True LD, Yeung RS.
    Cancer Res; 2002 Oct 15; 62(20):5645-50. PubMed ID: 12384518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13571-6. PubMed ID: 12271141
    [Abstract] [Full Text] [Related]

  • 6. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M, Wei J, Mizuguchi M, Greco A, Barness EG.
    Fetal Pediatr Pathol; 2004 Oct 15; 23(4):241-9. PubMed ID: 16095035
    [Abstract] [Full Text] [Related]

  • 7. Hamartin and tuberin expression in human tissues.
    Johnson MW, Kerfoot C, Bushnell T, Li M, Vinters HV.
    Mod Pathol; 2001 Mar 15; 14(3):202-10. PubMed ID: 11266527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL, Logginidou H, Klein-Szanto A, Henske EP.
    Mod Pathol; 1999 May 15; 12(5):539-45. PubMed ID: 10349994
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
    Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP.
    Cancer Res; 2007 Aug 01; 67(15):7106-12. PubMed ID: 17671177
    [Abstract] [Full Text] [Related]

  • 12. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.
    Kenerson H, Dundon TA, Yeung RS.
    Pediatr Res; 2005 Jan 01; 57(1):67-75. PubMed ID: 15557109
    [Abstract] [Full Text] [Related]

  • 13. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.
    Doğan V, Yeşil Ş, Kayalı Ş, Beken S, Özgür S, Ertuğrul İ, Bozkurt C, Örün UA, Karademir S.
    J Trop Pediatr; 2015 Feb 01; 61(1):74-7. PubMed ID: 25344617
    [Abstract] [Full Text] [Related]

  • 14. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
    Kwiatkowski DJ, Manning BD.
    Hum Mol Genet; 2005 Oct 15; 14 Spec No. 2():R251-8. PubMed ID: 16244323
    [Abstract] [Full Text] [Related]

  • 15. Tuberin activates the proapoptotic molecule BAD.
    Freilinger A, Rosner M, Krupitza G, Nishino M, Lubec G, Korsmeyer SJ, Hengstschläger M.
    Oncogene; 2006 Oct 19; 25(49):6467-79. PubMed ID: 16702951
    [Abstract] [Full Text] [Related]

  • 16. Dissociate expression of tuberous sclerosis complex 1 product hamartin in a skin and pulmonary lesion of a tuberous sclerosis complex.
    Wataya-Kaneda M, Katayama I.
    Hum Pathol; 2009 Mar 19; 40(3):430-4. PubMed ID: 18835623
    [Abstract] [Full Text] [Related]

  • 17. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
    Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, Wüthrich RP, Serra AL.
    Br J Dermatol; 2008 Aug 19; 159(2):473-5. PubMed ID: 18547304
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
    Lee L, Sudentas P, Donohue B, Asrican K, Worku A, Walker V, Sun Y, Schmidt K, Albert MS, El-Hashemite N, Lader AS, Onda H, Zhang H, Kwiatkowski DJ, Dabora SL.
    Genes Chromosomes Cancer; 2005 Mar 19; 42(3):213-27. PubMed ID: 15578690
    [Abstract] [Full Text] [Related]

  • 19. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A, Henske EP.
    Oncogene; 2005 Nov 14; 24(50):7475-81. PubMed ID: 16288294
    [Abstract] [Full Text] [Related]

  • 20. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
    Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G, Aronica E, Crino PB.
    Ann Neurol; 2004 Oct 14; 56(4):478-87. PubMed ID: 15455405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.